| 1 |
Zhu_X_2016 |
TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2.2.15 cells by activating the JAK–STAT signaling pathway |
Zhu, X; Xie, C; Li, Y-m; Huang, Z-l; Zhao, Q-y; Hu, Z-x; Wang, P-p; Gu, Y-r; Gao, Z-l; Peng, L |
2016 |
2016-06-02 |
COMM-USE |
N |
PMC5143376 |
27253403.0 |
10.1038/cddis.2016.146 |
fmtfzlb1 |
0.998357 |
|
|
| 2 |
Li_D_2017 |
A potent human neutralizing antibody Fc-dependently reduces established HBV infections |
Li, Dan; He, Wenhui; Liu, Ximing; Zheng, Sanduo; Qi, Yonghe; Li, Huiyu; Mao, Fengfeng; Liu, Juan; Sun, Yinyan; Pan, Lijing; Du, Kaixin; Ye, Keqiong; Li, Wenhui; Sui, Jianhua |
2017 |
2017-09-26 |
COMM-USE |
N |
PMC5614562 |
28949917.0 |
10.7554/elife.26738 |
ql6zo8ka |
0.811136 |
|
|
| 3 |
Fukuhara_2011 |
Intracellular delivery of serum-derived hepatitis C virus |
Fukuhara, Takasuke; Tani, Hideki; Shiokawa, Mai; Goto, Yukinori; Abe, Takayuki; Taketomi, Akinobu; Shirabe, Ken; Maehara, Yoshihiko; Matsuura, Yoshiharu |
2011 |
2011-04-30 |
PMC |
N |
PMC7129305 |
21262370.0 |
10.1016/j.micinf.2011.01.005 |
0808xjeq |
0.607328 |
|
|